Zobrazeno 1 - 10
of 528
pro vyhledávání: '"EA, Stein"'
Autor:
D L Sprecher, J Kobayashi, M Rymaszewski, IJ Goldberg, BV Harris, PS Bellet, D Ameis, R L Yunker, DM Black, EA Stein
Publikováno v:
Journal of Lipid Research, Vol 33, Iss 6, Pp 859-866 (1992)
A lipoprotein lipase (LpL) gene defect has been identified, a G—-A transition at nucleotide position 446 of exon 3, resulting in a premature termination codon (Trp—-stop) at amino acid residue 64. This defect was identified in a Type I hyperlipop
Externí odkaz:
https://doaj.org/article/920e1d9804774ed4a173f26ff9632a45
Autor:
MJ, Scarlata, RJ, Keeley, SA, Carmack, P-J, Tsai, JCM, Vendruscolo, H, Lu, GF, Koob, LF, Vendruscolo, EA, Stein
Publikováno v:
Addiction Neuroscience; March 2022, Issue: 1
Autor:
Se, Nissen, Re, Dent-Acosta, Rs, Rosenson, Stroes E, Sattar N, David Preiss, Gb, Mancini, Cm, Ballantyne, Catapano A, Gouni-Berthold I, Ea, Stein, Xue A, Sm, Wasserman, Scott R, Pd, Thompson, Gauss-, Investigators
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d1d612f6b274b1f65bd10b3928c44a8a
http://europepmc.org/abstract/med/26946077
http://europepmc.org/abstract/med/26946077
Autor:
Klug EQ; Tickerdoc Research, Netcare Sunninghill Hospital, Sandton, South Africa., Llerena S; Columbus Clinical Services, Miami, Florida., Burgess LJ; Tread Research, Tygerberg Hospital, Cape Town, South Africa., Fourie N; Iatros International, Bloemfontein, South Africa., Scott R; New Zealand Clinical Research, Christchurch, New Zealand., Vest J; Biostatistics, Medpace, Cincinnati, Ohio., Caldwell K; LIB Therapeutics, Cincinnati, Ohio., Kallend D; LIB Therapeutics, Cincinnati, Ohio., Stein EA; LIB Therapeutics, Cincinnati, Ohio.
Publikováno v:
JAMA cardiology [JAMA Cardiol] 2024 Sep 01; Vol. 9 (9), pp. 800-807.
Autor:
Venkatesh SK; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA.; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA-19104, USA., Stangl BL; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., Yan J; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., Quijano Cardé NA; Pharmacology Graduate Group, Biomedical Graduate Studies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA-19104, USA., Stein EA; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD- 21224, USA., Diazgranados N; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., Schwandt ML; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., Sun H; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., Momenan R; Clinical Neuroimaging Research Core, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., Goldman D; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA.; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA., De Biasi M; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA-19104, USA., Ramchandani VA; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD- 20892, USA.
Publikováno v:
The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.
Autor:
Steele VR; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States.; Olin Neuropsychiatry Research Center, The Institute of Living at Hartford Hospital, Hartford, CT, United States.; Center for Brain and Mind Health, Yale University, New Haven, CT, United States., Rotenberg A; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States., Philip NS; Department of Psychiatry and Human Behavior, The Warren Alpert Medical School, Brown University, Providence, RI, United States.; Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System & Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, United States., Hallett M; National Institute of Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda MD, United States., Stein EA; Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, United States., Salmeron BJ; Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, United States.
Publikováno v:
Frontiers in psychiatry [Front Psychiatry] 2024 Jul 09; Vol. 15, pp. 1391771. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).
Autor:
Cao Z; Shanghai Xuhui Mental Health Center, Shanghai, China.; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., McCabe M; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Callas P; Department of Mathematics and Statistics, University of Vermont College of Engineering and Mathematical Sciences, Burlington, VT, United States., Cupertino RB; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Ottino-González J; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Murphy A; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Pancholi D; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Schwab N; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Catherine O; Department of Psychological Sciences, School of Health Sciences, Swinburne University, Melbourne, VIC, Australia., Hutchison K; Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, United States., Cousijn J; Department of Psychology, Education and Child Studies, Erasmus University Rotterdam, Rotterdam, Netherlands., Dagher A; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada., Foxe JJ; Department of Neuroscience, The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States., Goudriaan AE; Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Hester R; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia., Li CR; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Thompson WK; Laureate Institute for Brain Research, Tulsa, OK, United States., Morales AM; Department of Psychiatry at Oregon Health and Science University, Portland, OR, United States., London ED; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, United States., Lorenzetti V; Neuroscience of Addiction and Mental Health Program, Healthy Brain and Mind Research Centre, School of Behavioural & Health Sciences, Faculty of Health Sciences, Australian Catholic University, Australia., Luijten M; Behavioural Science Institute, Radboud University, Nijmegen, Netherlands., Martin-Santos R; Department of Psychiatry and Psychology, University of Barcelona, Barcelona, Spain., Momenan R; Clinical NeuroImaging Research Core, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, United States., Paulus MP; Laureate Institute for Brain Research, Tulsa, OK, United States.; VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, CA, United States., Schmaal L; Orygen, Parkville, VIC, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia., Sinha R; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Solowij N; School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia., Stein DJ; SA MRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Stein EA; Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, United States., Uhlmann A; Department of Child and Adolescent Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany., van Holst RJ; Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Veltman DJ; Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Wiers RW; Addiction Development and Psychopathology (ADAPT)-Lab, Department of Psychology and Center for Urban Mental Health, University of Amsterdam, Amsterdam, Netherlands., Yücel M; BrainPark, Turner Institute for Brain and Mental Health, School of Psychological Sciences, and Monash Biomedical Imaging Facility, Monash University, Melbourne, VIC, Australia., Zhang S; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States., Conrod P; Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada., Mackey S; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States., Garavan H; Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT, United States.
Publikováno v:
Frontiers in neuroimaging [Front Neuroimaging] 2023 Dec 21; Vol. 2, pp. 1138193. Date of Electronic Publication: 2023 Dec 21 (Print Publication: 2023).
Autor:
Bonaventura J; Departament de Patologia i Terapèutica Experimental, Institut de Neurociències, Universitat de Barcelona, Neuropharmacology and Pain Group, Neuroscience Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Catalonia 08907, Spain.; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Boehm MA; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.; Department of Neuroscience, Brown University, Providence, RI 02906, USA., Jedema HP; Preclinical Pharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Solis O; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Pignatelli M; Department of Psychiatry and Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO 63110, USA., Song X; Preclinical Pharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Lu H; Magnetic Resonance Imaging and Spectroscopy Section, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Richie CT; Genetic Engineering and Viral Vector Core, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Zhang S; Confocal and Electron Microscopy Core, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Lam S; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Morales M; Neuronal Networks Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Gharbawie OA; Systems Neuroscience Center, Departments of Neurobiology and Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, USA., Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA., Stein EA; Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Bradberry CW; Preclinical Pharmacology Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA., Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Neuroimaging Research Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, MD 21224, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2023 Jul 26; Vol. 15 (706), pp. eadd1014. Date of Electronic Publication: 2023 Jul 26.
Autor:
Zhai T; Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland., Gu H; Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland., Salmeron BJ; Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland., Stein EA; Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland., Yang Y; Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland. Electronic address: yihongyang@intra.nida.nih.gov.
Publikováno v:
Biological psychiatry. Cognitive neuroscience and neuroimaging [Biol Psychiatry Cogn Neurosci Neuroimaging] 2023 Jun; Vol. 8 (6), pp. 672-679. Date of Electronic Publication: 2022 Sep 05.
Autor:
Wilson GH, Willett FR, Stein EA, Kamdar F, Avansino DT, Hochberg LR, Shenoy KV, Druckmann S, Henderson JM
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 04. Date of Electronic Publication: 2023 Feb 04.